Login

Orchard Therapeutics plc 3 SEC Filings

Filed On Filing
06 Nov 2020 Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others

Holds 9,111,848 shares of Ordinary shares

03 Feb 2020 Form 3: Altschuler Steven, Director

No securities owned

02 Jan 2020 Form 3: Fmr Llc, 10% owner

Holds 6,136,532 shares of Ordinary shares

02 Jan 2020 Form 3: Thomas Frank E, See Remarks

Holds 15,120 shares of Ordinary Shares

02 Jan 2020 Form 3: Secor Alicia, Director
02 Jan 2020 Form 3: Rowland Charles A Jr, Director

Holds 12,294 shares of Ordinary Shares

02 Jan 2020 Form 3: Rothera Mark, Director

Holds 93,796 shares of Ordinary Shares

02 Jan 2020 Form 3: Geraghty James A, Director

Holds 44,391 shares of Ordinary Shares

02 Jan 2020 Form 3: Gaspar Bobby, Director

Holds 348,319 shares of Ordinary Shares

02 Jan 2020 Form 3: Ellis Jon, Director

No securities owned

02 Jan 2020 Form 3: Dunoyer Marc, Director

Holds 37,179 shares of Ordinary Shares

02 Jan 2020 Form 3: Curnutte John T, Director
02 Jan 2020 Form 3: Beck Joanne T., Director

Holds 9,294 shares of Ordinary Shares

02 Jan 2020 Form 3: Glaxosmithkline Plc, Director

Holds 12,455,252 shares of Ordinary Shares, nominal value (GBP)0.10 per share

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support